Suchergebnisse - "Hashemian, Seyed Mohammad Reza"

PubPharm (104)

11

Nintedanib : a review of the properties, function, and usefulness to minimize COVID-19-induced lung injury

enthalten in: Expert review of anti-infective therapy | 2023

von Hashemian, S. | Farhadi, T. | Varahram, M. | +1

12

Applying bio-impedance vector analysis (BIVA) to adjust ultrafiltration rate in critically ill patients on continuous renal replacement therapy : A randomized controlled trial

enthalten in: Journal of critical care | 2022

von Rashid Farokhi, F. | Kalateh, E. | Shafaghi, S. | +4

13

National Research Institute of Tuberculosis and Lung Disease (NRITLD) Protocol for the Treatment of Patients with COVID-19

enthalten in: Iranian journal of pharmaceutical research : IJPR | 2022

von Mirenayat, M. | Abedini, A. | Kiani, A. | +33

14

Comprehensive overview of COVID-19-related respiratory failure : focus on cellular interactions

enthalten in: Cellular & molecular biology letters | 2022

von Zamani Rarani, F. | Zamani Rarani, M. | Hamblin, M. | +3

15

Comprehensive overview of COVID-19-related respiratory failure: focus on cellular interactions

enthalten in: Cellular & molecular biology letters | 2022

von Zamani Rarani, F. | Zamani Rarani, M. | Hamblin, M. | +3

16

Comprehensive overview of COVID-19-related respiratory failure: focus on cellular interactions

enthalten in: Cellular & molecular biology letters | 2022

von Zamani Rarani, F. | Zamani Rarani, M. | Hamblin, M. | +3

17

Comprehensive overview of COVID-19-related respiratory failure: focus on cellular interactions

enthalten in: Cellular & molecular biology letters | 2022

von Zamani Rarani, F. | Zamani Rarani, M. | Hamblin, M. | +3

18

Prognostic Value of Platelet to Lymphocyte Ratio (PLR) and Neutrophil to Lymphocyte Ratio (NLR) in Patients with Pulmonary Hypertension

enthalten in: Tanaffos | 2022

von Shahmoradi, Z. | Malekmohammad, M. | Najafi, G. | +5

19

RdRp inhibitors and COVID-19 : Is molnupiravir a good option?

enthalten in: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie | 2022

von Hashemian, S. | Pourhanifeh, M. | Hamblin, M. | +2

20

Mini review ATF4 and GRP78 as novel molecular targets in ER-Stress modulation for critical COVID-19 patients

enthalten in: Molecular biology reports | 2022

von Shahriari-Felordi, M. | Alikhani, H. | Hashemian, S. | +2